COSTAR

Serial Number 97468971
606

Registration Progress

Application Filed
Jun 21, 2022
Under Examination
Jul 4, 2023
Approved for Publication
May 9, 2023
Published for Opposition
May 9, 2023
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: COSTAR
Previous Owner: Instil Bio, Inc.
Classes: 005, 040, 041

Trademark Image

COSTAR

Basic Information

Serial Number
97468971
Filing Date
June 21, 2022
Published for Opposition
May 9, 2023
Abandonment Date
October 7, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 7, 2025
Classes
005 040 041

Rights Holder

Instil Bio, Inc.

03
Address
3963 Maple Avenue, Suite 350
DALLAS, TX 75219

Ownership History

Instil Bio, Inc.

Original Applicant
03
DALLAS, TX

Instil Bio, Inc.

Owner at Publication
03
DALLAS, TX

Legal Representation

Attorney
Richard Y. Kim

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

30 events
Date Code Type Description Documents
Oct 7, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 7, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 26, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 26, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 26, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 4, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 2, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 2, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 2, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 19, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 19, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 19, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 19, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 19, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 4, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 16, 2023 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
Jun 12, 2023 APET A ASSIGNED TO PETITION STAFF Loading...
May 30, 2023 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
May 9, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 9, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 19, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 31, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 31, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 31, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 31, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 31, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 31, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 8, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 24, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Cells for medical or clinical use; cells featuring digested tumor tissue and increased lymphocytes for medical or clinical use; biological preparations for the treatment of cancer and cellular disorders; reagents for medical use; drug delivery agents consisting of compounds that facilitate the preservation and delivery of a wide range of pharmaceuticals; all of the aforesaid (goods/services) relating to the development and research of cell and gene therapy for the treatment of cancer
Class 040
Custom manufacture of biological preparations, pharmaceutical preparations and cell therapy preparations; all of the aforesaid (goods/services) relating to the development and research of cell and gene therapy for the treatment of cancer
Class 041
Providing online non-downloadable publications in the nature of articles, newsletters and brochures in the fields of cancer treatment and cell therapies; educational services, namely, conducting programs in the field of cancer treatment and cell therapies; educational services, namely, arranging and conducting classes, seminars and workshops in the fields of cancer treatment and cell therapies; all of the aforesaid (goods/services) relating to the development and research of cell and gene therapy for the treatment of cancer

Classification

International Classes
005 040 041